Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/40233
Title: A novel direct adenosine monophosphate kinase activator ameliorates disease progression in preclinical models of Autosomal Dominant Polycystic Kidney Disease
Authors: Dagorn, Pascale Gluais
Buchholz, Bjoern
Kraus, Andre
Batchuluun, Battsetseg
Bange, Hester
BLOCKKEN, Laura 
Steinberg, Gregory R.
Moller, David E.
Hallakou-Bozec, Sophie
Issue Date: 2023
Publisher: ELSEVIER SCIENCE INC
Source: KIDNEY INTERNATIONAL, 103 (5) , p. 917 -929
Abstract: A novel direct adenosine monophosphate kinase activator ameliorates disease progression in preclinical models of Autosomal Dominant Polycystic Kidney Disease
Notes: Hallakou-Bozec, S (corresponding author), Poxel SA, 259 Av Jean Jaures, F-69007 Lyon, France.
sophie.bozec@poxelpharma.com
Keywords: ADPKD;AMPK;PXL770;fibrosis;inflammation;mitochondria;Mice;Animals;Dogs;Adenosine Monophosphate;AMP-Activated Protein Kinases;Kidney;Mice, Knockout;Disease Progression;TRPP Cation Channels;Polycystic Kidney, Autosomal Dominant;Renal Insufficiency;Cysts
Document URI: http://hdl.handle.net/1942/40233
ISSN: 0085-2538
e-ISSN: 1523-1755
DOI: 10.1016/j.kint.2023.01.026
ISI #: 000984794600001
Rights: 2023, International Society of Nephrology. Published by Elsevier Inc. This is an open access article under the CC BY license (http:// creativecommons.org/licenses/by/4.0/).
Category: A1
Type: Journal Contribution
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
A novel direct adenosine monophosphate kinase activator ameliorates disease progression in preclinical models of Autosomal Dominant Polycystic Kidney Disease.pdfPublished version2.65 MBAdobe PDFView/Open
Show full item record

SCOPUSTM   
Citations

16
checked on Sep 8, 2025

WEB OF SCIENCETM
Citations

16
checked on Sep 11, 2025

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.